• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

NuTech Medical acquired by Organogenesis

March 28, 2017 By Sarah Faulkner

Organogenesis acquires NuTech MedicalOrganogenesis said today that it acquired NuTech Medical for an undisclosed price. The combined company plans to feature a portfolio of wound care products and surgical biologics.

Birmingham, Alabama-based NuTech Medical will keep it’s non-biologics product line as a separate company called NuTech Spine.

“This is an important transaction for the regenerative medicine field.  It unites 2 pioneering companies, each with decades of experience in bringing quality biologics products to patients around the world,” Organogenesis president & CEO Gary Gillheeney, Sr., said in prepared remarks. “This is a compelling, highly complementary combination of best-in-class, innovative products in both the regenerative wound and surgical biologics markets. Organogenesis is currently growing at 40% a year, and we have patiently waited to enter the amniotic tissue space.  Specifically, we’ve been watching the development of next-generation amniotic products, and we’ve found in NuTech Medical what we believe is the field’s most promising product portfolio and pipeline, with a technology platform that’s really unparalleled in the field.”

NuTech’s president & CEO, Howard Walthall, will join Organogenesis as president of the company’s surgical division and senior VP for strategy and development.

“This is an exciting time for NuTech Medical, as we share with Organogenesis a commitment to regenerative product innovation, and a culture of scientific advancement and exceptional customer service,” Walthall added. “Like NuTech, Organogenesis has decades of experience bringing ground-breaking technology to market, and building a large and loyal customer base.  This acquisition enables us to drive significant growth in both the wound and surgical biologics markets together, through our combined R&D programs, and our strong and proven distribution networks.”

NuTech has developed amniotic allografts for soft tissue and bone applications, including Affinity, NuShield, NuCel and ReNu.

Yesterday, Organogenesis launched its PuraPly Antimicrobial clinical research program, which will evaluate patients treated with PuraPly AM for up to 12 weeks. The 1st studies have started enrolling patients, according to Organogenesis.

The Canton, Mass.-based company’s PuraPly AM is a 510(k)-cleared device indicated for the management of acute and chronic wounds. The device is made of a bi-layered purified Type I collagen sheet, loaded with a broad spectrum antimicrobial agent that acts as a barrier against microbial colonization within wound dressings.

The NY-based studies will evaluate the device as an antimicrobial wound management therapy, as well as its ability to manage bioburden, support granulation tissue formation and support wound closure, Organogenesis reported.

Filed Under: Featured, Mergers & Acquisitions, Regenerative Medicine, Surgical, Wall Street Beat Tagged With: NuTech Medical, Organogenesis

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS